Grifols SA (GRFS)
9.545
+0.48
(+5.24%)
USD |
NASDAQ |
Nov 14, 16:00
9.545
0.00 (0.00%)
After-Hours: 20:00
Grifols Shareholders Equity (Quarterly): 5.975B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.975B |
| June 30, 2024 | 5.995B |
| December 31, 2023 | 6.441B |
| September 30, 2023 | 6.486B |
| June 30, 2023 | 6.370B |
| December 31, 2022 | 6.574B |
| June 30, 2022 | 6.612B |
| June 30, 2021 | 6.150B |
| March 31, 2021 | 6.357B |
| December 31, 2020 | 6.283B |
| September 30, 2020 | 6.278B |
| June 30, 2020 | 6.034B |
| March 31, 2020 | 6.114B |
| December 31, 2019 | 5.402B |
| September 30, 2019 | 5.221B |
| June 30, 2019 | 4.996B |
| March 31, 2019 | 4.942B |
| December 31, 2018 | 4.834B |
| September 30, 2018 | 4.817B |
| June 30, 2018 | 4.587B |
| March 31, 2018 | 4.568B |
| December 31, 2017 | 4.354B |
| September 30, 2017 | 4.221B |
| June 30, 2017 | 4.094B |
| March 31, 2017 | 4.072B |
| Date | Value |
|---|---|
| December 31, 2016 | 3.934B |
| September 30, 2016 | 3.958B |
| June 30, 2016 | 3.791B |
| March 31, 2016 | 3.732B |
| December 31, 2015 | 3.604B |
| September 30, 2015 | 3.599B |
| June 30, 2015 | 3.443B |
| March 31, 2015 | 3.391B |
| December 31, 2014 | 3.232B |
| September 30, 2014 | 3.216B |
| June 30, 2014 | 3.045B |
| March 31, 2014 | 3.053B |
| December 31, 2013 | 2.902B |
| September 30, 2013 | 2.648B |
| June 30, 2013 | 2.524B |
| March 31, 2013 | 2.506B |
| December 31, 2012 | 2.482B |
| September 30, 2012 | 2.389B |
| June 30, 2012 | 2.278B |
| March 31, 2012 | 2.240B |
| December 31, 2011 | 2.153B |
| September 30, 2011 | 2.168B |
| June 30, 2011 | 2.172B |
| December 31, 2010 | 921.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.402B
Minimum
Dec 2019
6.612B
Maximum
Jun 2022
6.219B
Average
6.280B
Median
Shareholders Equity (Quarterly) Benchmarks
| Cellectis SA | 129.42M |
| Adaptimmune Therapeutics PLC | 96.27M |
| Akari Therapeutics PLC | -3.703M |
| Biodexa Pharmaceuticals PLC | 11.04M |
| Verona Pharma PLC | 130.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.65B |
| Total Liabilities (Quarterly) | 13.73B |
| Current Ratio | 2.260 |
| Net Debt Paydown Yield | 31.04% |